Stocktoria
Gerresheimer AG GXI.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Gerresheimer AG financials (annual)
Bars are annual figures from 2021 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | €2.0B | €2.0B | €1.8B | €1.5B |
| Gross profit | €607.8M | €597.3M | €546.8M | €446.3M |
| R&D expense | €22.4M | €16.1M | €21.6M | €10.0M |
| SG&A expense | €341.7M | €326.0M | €304.6M | €244.7M |
| Operating income | €233.6M | €229.5M | €193.7M | €189.4M |
| Interest expense | €60.6M | €50.4M | €28.0M | €20.7M |
| Income tax | €34.5M | €47.3M | €38.6M | €40.6M |
| Net income | €109.7M | €116.1M | €96.1M | €83.8M |
| EPS (diluted) | €3.18 | €3.48 | €3.06 | €2.67 |
| Operating cash flow | €240.3M | €294.3M | €221.9M | €212.1M |
| Free cash flow | -€129.5M | -€33.7M | -€19.6M | €8.4M |
| Cash & equivalents | €186.4M | €122.3M | €112.8M | €114.1M |
| Inventory | €349.7M | €323.3M | €304.4M | €235.4M |
| Goodwill | €676.4M | €670.1M | €684.8M | €656.2M |
| Total assets | €3.8B | €3.4B | €3.4B | €2.9B |
| Total debt | €1.3B | €1.0B | €1.2B | €1.1B |
| Total liabilities | €2.3B | €2.0B | €2.1B | €1.9B |
| Shareholders' equity | €1.5B | €1.4B | €1.2B | €993.8M |
Growth · year-over-year · Revenue CAGR 10.8%
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue growth | +2.3% | +9.5% | +21.3% | — |
| Net income growth | -5.5% | +20.8% | +14.7% | — |
| EPS growth | -8.6% | +13.7% | +14.6% | — |
| Free cash flow growth | — | — | -331.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · DE · as of 2024-11-30. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.